Inducible down-regulation of MHC class I results in natural killer cell tolerance
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Inducible down-regulation of MHC class I results in natural killer cell tolerance
Authors
Keywords
-
Journal
JOURNAL OF EXPERIMENTAL MEDICINE
Volume 216, Issue 1, Pages 99-116
Publisher
Rockefeller University Press
Online
2018-12-18
DOI
10.1084/jem.20181076
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- First-in-human phase 1 clinical study of the IL-15 superagonist complex ALT-803 to treat relapse after transplantation
- (2018) Rizwan Romee et al. BLOOD
- Next generation natural killer cells for cancer immunotherapy: the promise of genetic engineering
- (2018) May Daher et al. CURRENT OPINION IN IMMUNOLOGY
- Immunoreceptor tyrosine-based inhibitory motif–dependent functions of an MHC class I-specific NK cell receptor
- (2017) Michael D. Bern et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Checkpoint Inhibition of KIR2D with the Monoclonal Antibody IPH2101 Induces Contraction and Hyporesponsiveness of NK Cells in Patients with Myeloma
- (2016) M. Carlsten et al. CLINICAL CANCER RESEARCH
- Differential Role of Hematopoietic and Nonhematopoietic Cell Types in the Regulation of NK Cell Tolerance and Responsiveness
- (2016) Nataliya Tovbis Shifrin et al. JOURNAL OF IMMUNOLOGY
- IL-15 Superagonist–Mediated Immunotoxicity: Role of NK Cells and IFN-γ
- (2015) Yin Guo et al. JOURNAL OF IMMUNOLOGY
- Dual Requirement of Cytokine and Activation Receptor Triggering for Cytotoxic Control of Murine Cytomegalovirus by NK Cells
- (2015) Bijal A. Parikh et al. PLoS Pathogens
- A phase II trial of pan-KIR2D blockade with IPH2101 in smoldering multiple myeloma
- (2014) N. Korde et al. HAEMATOLOGICA
- Cytokine therapy reverses NK cell anergy in MHC-deficient tumors
- (2014) Michele Ardolino et al. JOURNAL OF CLINICAL INVESTIGATION
- Cutting Edge: Viral Infection Breaks NK Cell Tolerance to "Missing Self"
- (2014) J. C. Sun et al. JOURNAL OF IMMUNOLOGY
- Controlling Natural Killer Cell Responses: Integration of Signals for Activation and Inhibition
- (2013) Eric O. Long et al. Annual Review of Immunology
- Natural killer cell licensing in mice with inducible expression of MHC class I
- (2013) T. Ebihara et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Tolerance and exhaustion: defining mechanisms of T cell dysfunction
- (2013) Andrea Schietinger et al. TRENDS IN IMMUNOLOGY
- Generation of CD4CreERT2transgenic mice to study development of peripheral CD4-T-cells
- (2012) Katayoun Aghajani et al. GENESIS
- T-Cell Tolerance: Central and Peripheral
- (2012) Y. Xing et al. Cold Spring Harbor Perspectives in Biology
- Natural killer cells act as rheostats modulating antiviral T cells
- (2011) Stephen N. Waggoner et al. NATURE
- Natural Killer Cell Education and Tolerance
- (2010) Mark T. Orr et al. CELL
- Mature natural killer cells reset their responsiveness when exposed to an altered MHC environment
- (2010) Nathalie T. Joncker et al. JOURNAL OF EXPERIMENTAL MEDICINE
- MHC class I–deficient natural killer cells acquire a licensed phenotype after transfer into an MHC class I–sufficient environment
- (2010) Julie M. Elliott et al. JOURNAL OF EXPERIMENTAL MEDICINE
- In vivotumor cell rejection induced by NK cell inhibitory receptor blockade: Maintained tolerance to normal cells even in the presence of IL-2
- (2009) Gustaf Vahlne et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Distinct and complementary functions of MDA5 and TLR3 in poly(I:C)-mediated activation of mouse NK cells
- (2009) Stephen McCartney et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Stability of Murine Cytomegalovirus Genome after In Vitro and In Vivo Passage
- (2009) T. P. Cheng et al. JOURNAL OF VIROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More